Researchers have developed a novel approach to detect ALS and predict survival by measuring genetic activity in blood cells, a study found.

NetraMark Holdings Inc., in collaboration with the Centre for Addiction and Mental Health (CAMH), has been awarded the Ontario Research Fund – Research Excellence Award to advance AI-driven research ...

NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier artificial intelligence (AI) company transforming clinical trials with AI-powered ...

An AI-driven computational toolkit, Gcoupler, integrates ligand design, statistical modeling, and graph neural networks to predict endogenous metabolites that allosterically modulate the GPCR–Gα ...

Researchers developed a blood test that spots ALS with 90% accuracy. The 46-gene panel could cut diagnostic delays that now ...

Tested across eight lettuce types, the system successfully visualizes pigment spatial distribution from individual leaves to full canopies, offering a ...

Drug development in biotechnology takes time. A lot of time. On average, it takes 10 to 15 years to take a medicine from ...

A new portable DNA test can identify dozens of shark and ray species in only two hours, giving frontline officers a powerful ...

The AI’s learned behavior shows a clear preference for high-density, mixed-use development, increasing the spatial clustering ...

But tools using AI such as machine learning have been shown to help doctors select the embryos that have the best chance of ...

The inaugural competition surprisingly awarded two $100,000 grand prizes to address challenges in defining robust benchmarks for complex biology.

Although artificial intelligence can make the health care workflow more efficient, human supervision is still needed to ...